Phil Reilly

CEO, Interleukin Genetics Incorporated

Interleukin Genetics is a biotechnology company that focuses on understanding the genetics of inflammation, an important function of the body's defense system. Quixtar's parent company, Alticor, owns a majority interest in ILGN, and Quixtar's Personalized Health program features a genetic test developed by ILGN.

Phil Reilly is a well-known and respected leader in the field of genetics. He recognizes the importance of the partnership between Quixtar and ILGN in combining the knowledge bases of the two organizations. Partnering the nutritional science expertise behind Quixtar's Nutrilite^® brand with ILGN's extensive knowledge of genes has placed these companies at the forefront of personalized nutrition. Harnessing the assets of both companies promises to spark an exciting line of new products to protect and promote health.